Building a fast-lane to novel therapies: Aitia CEO Colin Hill at Orion Day on October 6 in Espoo, Finland.
Accelerating Drug Target Identification and Validation with AI and Digital Twins: Join our CBO, Joseph Donahue at BioTechX Europe 2023
Revolutionizing drug discovery and development with AI and Digital Twins: Join Aitia CBO, Joseph Donahue at BioTechX Europe 2023 in Basel.
CEO and Investor Roundtable Discussion: Join our CEO, Colin Hill at BioCentury East-West Pharma Summit 2023
Join Aitia’ CEO Colin Hill on the Roundtable discussion at East-West Pharma Summit to explore the future for Biotechs with industry experts Christine Aylward, Founding & Managing Partner, Magnetic Ventures, Nathalie Beslay, Co-Founder, NAAIA, Michelle Chen, Board Member, BayHelix & CBO, Insilico Medicine, and Alan Jiang, Director & Chief Strategy Officer, XtalPi on October 4 in Cambridge, MA.
Driving Research in Pancreatic Cancer: Join our CEO, Colin Hill on the PanCAN Scientific Summit 2023
Driving the drug discovery of Pancreatic Cancer: Join Aitia CEO Colin Hill at the PanCAN Scientific Summit 2023 conference on September 27th
Exploring the latest topics in the biopharma ecosystem: Join Aitia’ CEO Colin Hill at the Longwood Healthcare Leaders Fall Conference on September 19 in Boston.
Webinar | From the beta-amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s Disease
Join in our upcoming webinar and hear from renowned expert Dr. Rudolf Tanzi, John Dwyer, President of GAP Foundation and Colin Hill on the latest discoveries and developments that have been made to unlock the biological complexity of Alzheimer’s disease.
Realizing AI’s Potential in Drug Discovery: Join our CEO, Colin Hill on the Top of Mind for Life Sciences Summit 2023
Unlocking the future AI application in drug discovery: Join Aitia CEO Colin Hill at the Top of Mind for Life Sciences Summit 2023 conference on September 12 in Pittsburgh.
On July 20th, we had the privilege to visit the cutting-edge Servier Paris-Saclay R&D Institute in France, where our CEO, Colin Hill delivered a keynote titled: “Why AI and Digital Twins will Drive the Discovery and Development of the Next Generation of Breakthrough Drugs”.
Alzheimer’s Disease Mechanistic Pathways Discovered through Aitia’s Digital Twins and in silico Experiments in Causal AI to be Presented at AAIC 2023
We are delighted to announce that Aitia will be at the upcoming Alzheimer’s Association International Conference (AAIC) being held from July 16-20 in Amsterdam, Netherlands.
We are thrilled to announce that Aitia will be participating in the highly anticipated Aspen Ideas: Health conference. Our CEO, Colin Hill, will be taking the stage on a thought-provoking panel titled “Open to Debate: Is the FDA too Cautious?”